Patents for A61K 9 - Medicinal preparations characterised by special physical form (299,044) |
---|
09/23/2010 | WO2010107040A1 Solid preparation containing npy y5 receptor antagonist |
09/23/2010 | WO2010106981A1 Base material for spraying comprising low-molecular gelling agent |
09/23/2010 | WO2010106936A1 Orally disintegrating tablet |
09/23/2010 | WO2010106571A2 Ophthalmic compositions based on polyunsaturated omega-3 and omega-6 fatty acids |
09/23/2010 | WO2010106555A2 Directly compressible pre-granulated cellulose ether polymer and process for preparing the same |
09/23/2010 | WO2010106502A1 A novel dermaceutical cream made using sodium fusidate, clotrimazole and clobetasol propionate, a process to make the same and a method of treatment using it |
09/23/2010 | WO2010106465A1 A dermaceutical cream made using sodium fusidate, clotrimazole and fluticasone propionate |
09/23/2010 | WO2010106459A1 A dermaceutical cream made using sodium fusidate, clotrimazole and mometasone furoate |
09/23/2010 | WO2010106313A1 Improvement in solubility of drugs by means of hyaluronic acid |
09/23/2010 | WO2010106191A1 Pharmaceutical composition presenting anti-inflammatory properties |
09/23/2010 | WO2010106095A1 In situ constituting a vaccine for administration to a predetermined herd of animals |
09/23/2010 | WO2010106063A2 Composite materials loaded with therapeutic and diagnostic agents comprising polymer nanoparticles and polymer fibers |
09/23/2010 | WO2010106050A1 A particle stabilised oil-in-water emulsion |
09/23/2010 | WO2010106046A1 Macrocyclic lactone drug delivery system |
09/23/2010 | WO2010105995A2 Zoo-technical drug delivery device |
09/23/2010 | WO2010105991A1 Method of creating salt aerosol for breathing by nebulizing an aqueous saline solution |
09/23/2010 | WO2010105842A2 Preparation for external application |
09/23/2010 | WO2010105824A1 Retigabine tablets, preferably having modified release |
09/23/2010 | WO2010105823A1 Solid retigabine in non-crystalline form |
09/23/2010 | WO2010105822A2 Dry processing of retigabine |
09/23/2010 | WO2010105673A1 Controlled release pharmaceutical composition with resistance against the influence of ethanol employing a coating comprising a polymer mixture and excipients |
09/23/2010 | WO2010105672A1 Controlled release pharmaceutical composition with resistance against the influence of ethanol employing a coating comprising neutral vinyl polymers and excipients |
09/23/2010 | WO2010105448A1 A chinese medicinal composition for external use in treatment and health care of renal function and its use in manufacture of cataplasm |
09/23/2010 | WO2010105372A1 Compositions and methods for silencing hepatitis c virus expression |
09/23/2010 | WO2010105342A1 Transdermal pharmaceutical preparation and administration of tirofiban |
09/23/2010 | WO2010088537A3 Improved lipid formulation for the delivery of nucleic acids |
09/23/2010 | WO2010081722A3 Orally disintegrating tablets for the treatment of pain |
09/23/2010 | WO2010065563A3 Apratoxin therapeutic agents: mechanism and methods of treatment |
09/23/2010 | WO2010065069A3 Compositions comprising renin-angiotensin aldosterone system inhibitors and lipoic acid compounds, and the use thereof for the treatment of renin-angiotensin aldosterone system related disorders |
09/23/2010 | WO2010062824A3 Enhanced bioactive formulations of resveratrol |
09/23/2010 | WO2010058297A9 The use of ph-sensitive, acid-stable metal-binding nanoparticles |
09/23/2010 | WO2010038091A3 Compositions comrrising amlodipine and bisoprolol |
09/23/2010 | WO2010033800A3 Stable tetracycline aqueous formulations |
09/23/2010 | WO2010031720A3 Novel antibody formulation |
09/23/2010 | WO2010004018A3 Degradable microcapsules |
09/23/2010 | WO2009135948A3 Process for preparing a high drug load tablet |
09/23/2010 | WO2009100716A3 Implantable products comprising nanoparticles |
09/23/2010 | WO2009097332A3 Therapeutic compositions comprising an amine-containing lipid and a protein |
09/23/2010 | US20100241219 Medicament delivery article, accessory & system |
09/23/2010 | US20100240899 when the plasma nicotinic acid or nicotinuric acid curves are deconvoluted using the Wagner-Nelson method; side effect reduction |
09/23/2010 | US20100240771 Process for preparing aqueous-alcoholic solution and products based thereon |
09/23/2010 | US20100240761 Bronchodilating beta-agonist compositions and methods |
09/23/2010 | US20100240742 Anti-angiogenic compositions and methods of use |
09/23/2010 | US20100239686 Method For Making Nanolipidic Particles |
09/23/2010 | US20100239685 Compound for treatment or prevention of prostate-related diseases and pharmaceutical composition of colon delivery system containing the same |
09/23/2010 | US20100239684 Granular jelly beverage for medication and process for producing the same |
09/23/2010 | US20100239683 Sustained release of microcrystalline peptide suspensions |
09/23/2010 | US20100239682 Colonic delivery of antimicrobial agents |
09/23/2010 | US20100239681 Controlled Release Particulates Containing Water-Insoluble Drug |
09/23/2010 | US20100239680 Powder Cosmetic Composition |
09/23/2010 | US20100239678 Ionically functionalized nanodiamonds |
09/23/2010 | US20100239677 Nonaerosol/aerosol dispensing of sunscreen sprays comprising silica microparticles |
09/23/2010 | US20100239676 Stable Aerosolizable Suspensions of Proteins in Ethanol |
09/23/2010 | US20100239675 Plasmon mediated photoinduced synthesis of silver triangular bipyramids |
09/23/2010 | US20100239674 Pharmaceutical composition for the treatment and prevention of diseases involving impotence |
09/23/2010 | US20100239673 Blood compatible nanomaterials and methods of making and using the same |
09/23/2010 | US20100239672 Layer silicate nanocomposites of polymer hydrogels and their use in tissue expanders |
09/23/2010 | US20100239671 Tissue-Engineered Endothelial and Epithelial Implants Differentially and Synergistically Regulate Tissue Repair |
09/23/2010 | US20100239670 Topical Composition Method for Treating Urinary Stress Incontinence |
09/23/2010 | US20100239669 Combinations of statins and anti-obesity agent |
09/23/2010 | US20100239668 Segmented pharmaceutical dosage forms |
09/23/2010 | US20100239667 Controlled release pharmaceutical compositions for prolonged effect |
09/23/2010 | US20100239666 Process for producing mouldings from (meth) acrylate copolymers by means of injection moulding |
09/23/2010 | US20100239665 Pharmaceutical nimodipine compositions |
09/23/2010 | US20100239664 Forms of rifaximin and uses thereof |
09/23/2010 | US20100239663 Composition for foodstuff for binding acetaldehyde |
09/23/2010 | US20100239662 Misuse preventative, controlled release formulation |
09/23/2010 | US20100239661 Pharmaceutical compositions of ursodiol |
09/23/2010 | US20100239660 Product and use of omega-3s matching human tissue ratios for treatment of inflammatory and other conditions |
09/23/2010 | US20100239659 Self-assembling amphiphilic polymers as anti-cancer agents |
09/23/2010 | US20100239658 Gallium nitrate formulations |
09/23/2010 | US20100239657 Composite for liver-specific delivery and release of therapeutic nucleic acids or drugs |
09/23/2010 | US20100239656 Egfr/nedd9/tgf-beta interactome and methods of use thereof for the identification of agents having efficacy in the treatment of hyperproliferative disorders |
09/23/2010 | US20100239655 Taurine-based compositions and therapeutic methods |
09/23/2010 | US20100239654 Vesicular phospholipid gels comprising proteinaceous substances |
09/23/2010 | US20100239653 Pharmaceutical preparations and methods for inhibiting tumors |
09/23/2010 | US20100239652 Immunoliposomes for treatment of cancer |
09/23/2010 | US20100239650 Isothiazolin biodelivery systems |
09/23/2010 | US20100239649 Tumor Suppressor Factor |
09/23/2010 | US20100239648 Self-locating, multiple application, and multiple location medical patch systems and methods therefor |
09/23/2010 | US20100239647 Photoresponsive ionogel |
09/23/2010 | US20100239646 Sublingual methotrexate and methotrexate patches |
09/23/2010 | US20100239645 Methods and Compositions for Wound Healing |
09/23/2010 | US20100239643 Anti-itch sheet |
09/23/2010 | US20100239642 Coating compositions |
09/23/2010 | US20100239641 Warming vapor pad |
09/23/2010 | US20100239640 Skin-derived precursor cells and uses thereof |
09/23/2010 | US20100239639 Medicated patch |
09/23/2010 | US20100239638 Chewable soft capsule having improved ingestion property and method for producing same |
09/23/2010 | US20100239637 Contact lens drug delivery device |
09/23/2010 | US20100239635 Drug delivery medical device |
09/23/2010 | US20100239633 Immunoglobulin constant region fc receptor binding agents |
09/23/2010 | US20100239632 Drug depots for treatment of pain and inflammation in sinus and nasal cavities or cardiac tissue |
09/23/2010 | US20100239631 Thiopyrimidine-based compounds and uses thereof |
09/23/2010 | US20100239621 Gel sheet and cosmetic preparation in sheet form using the same |
09/23/2010 | US20100239617 Modified rsv f proteins and methods of their use |
09/23/2010 | US20100239616 Controlled activation ingestible identifier |
09/23/2010 | US20100239524 Microparticles prepared using an ionic liquid |
09/23/2010 | US20100239513 Aqueous compositions comprising vesicles having certain vesicle permeability |
09/23/2010 | US20100239507 Surface modified aerosol particles, a method and apparatus for production thereof and powders and dispersions containing said particles |